Results
3
3 companies
Beijing Luzhu Biotechnology
Market Cap: HK$4.6b
A biotechnology company, focuses on the research and development, production, and sale of human vaccines and therapeutic biologics to prevent and control infectious diseases, and treat cancer and autoimmune diseases in Mainland China.
2480
HK$23.30
7D
0.7%
1Y
4.0%
CanSino Biologics
Market Cap: HK$16.5b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$47.08
7D
-1.2%
1Y
139.7%
Cutia Therapeutics
Market Cap: HK$2.6b
An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.
2487
HK$8.25
7D
-7.8%
1Y
6.2%